{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:58:41Z","timestamp":1792393121732,"version":"4.4.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>The 2017 American College of Cardiology (ACC)\/American Heart Association (AHA) (US) Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults expanded the definition of hypertension and now considers atherosclerotic cardiovascular disease (ASCVD) risk in determining treatment for people with hypertension. US guidelines are influential around the world and it is therefore justified to study their impact in other settings. Our study determined the impact of adopting the 2017 ACC\/AHA guideline in China.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We analyzed the population impact of the 2017 ACC\/AHA guideline using the 2011\u20132012 year of the China Health and Retirement Longitudinal Study (CHARLS), a nationally representative sample of Chinese adults 45\u201374 years of age (n = 11,822). Our analysis was unique because for the first time it used a population-appropriate equation to calculate ASCVD risk instead of the US Pooled Cohort Equation (the latter misrepresents risk in non-US populations).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Adopting the 2017 ACC\/AHA guideline in China would increase the prevalence of hypertension from 44.1% to 56.4% (12.3 percentage points) and increase the number of adults recommended for antihypertensive medication from 41.6% to 49.1% (7.5 percentage points) in the 45\u201374-year age range. According to Chinese (but not US) risk calculations, the 2017 ACC\/AHA guideline more selectively assigns antihypertensive medication to patients at higher risk for ASCVD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>The 2017 ACC\/AHA guideline brings potential for risk reduction in China and selectively recommends medication for those who would benefit most. Realizing such benefits would ultimately depend on the acceptance, adherence, and feasibility of adopting this guideline.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajh\/hpaa094","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T19:10:30Z","timestamp":1591643430000},"page":"846-851","source":"Crossref","is-referenced-by-count":4,"title":["Potential Impact of the 2017 High Blood Pressure Guideline Beyond the United States: A Case Study of the People\u2019s Republic of China"],"prefix":"10.1093","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-9655","authenticated-orcid":false,"given":"Andrew","family":"Barszczyk","sequence":"first","affiliation":[{"name":"The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University , Hangzhou, Zhejiang, China"},{"name":"Department of Physiology, University of Toronto , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deye","family":"Yang","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University , Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wei","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University , Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Physiology, University of Toronto , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Ping","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Physiology, University of Toronto , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Lee","sequence":"additional","affiliation":[{"name":"Dr. Eric Jackman Institute of Child Study, University of Toronto , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Luo","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University , Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"2022100315501636800_CIT0001","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jash.2018.01.004","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"12","author":"Brook","year":"2018","journal-title":"J Am Soc Hypertens"},{"key":"2022100315501636800_CIT0002","article-title":"Cardiovascular diseases in China","author":"Liu","year":"2007","journal-title":"Biochem Cell Biol"},{"key":"2022100315501636800_CIT0003","first-page":"182","article-title":"2018 Chinese guidelines for prevention and treatment of hypertension\u2014a report of the Revision Committee of Chinese guidelines for prevention and treatment of hypertension","volume":"16","author":"Joint Committee for Guideline Revision.","year":"2019","journal-title":"J Geriatr Cardiol"},{"key":"2022100315501636800_CIT0004","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/CIRCULATIONAHA.116.022367","article-title":"Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (Prediction for ASCVD Risk in China)","volume":"134","author":"Yang","year":"2016","journal-title":"Circulation"},{"key":"2022100315501636800_CIT0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"2022100315501636800_CIT0006","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ajh.2011.248a","article-title":"2010 Chinese guidelines for the management of hypertension","volume":"25","author":"Sun","year":"2012","journal-title":"Am J Hypertens"},{"key":"2022100315501636800_CIT0007","doi-asserted-by":"crossref","first-page":"k2357","DOI":"10.1136\/bmj.k2357","article-title":"Impact of 2017 ACC\/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study","volume":"362","author":"Khera","year":"2018","journal-title":"BMJ"},{"key":"2022100315501636800_CIT0008","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"2022100315501636800_CIT0009","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.scib.2018.03.006","article-title":"Prevalence and treatment of hypertension in China: impacts of 2017 American College of Cardiology\/American Heart Association High Blood Pressure Guideline","volume":"63","author":"Yang","year":"2018","journal-title":"Sci Bull"},{"key":"2022100315501636800_CIT0010","doi-asserted-by":"crossref","first-page":"e002276","DOI":"10.1161\/JAHA.115.002276","article-title":"Reducing the blood pressure-related burden of cardiovascular disease: impact of achievable improvements in blood pressure prevention and control","volume":"4","author":"Hardy","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2022100315501636800_CIT0011","article-title":"N Engl J","author":"SPRINT Research","year":"2103\u20132116","journal-title":"Med 2015; 373:"},{"key":"2022100315501636800_CIT0012","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","article-title":"Blood-pressure lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Lonn","year":"2016","journal-title":"N Engl J Med"},{"key":"2022100315501636800_CIT0013","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)32478-9","article-title":"Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)","author":"Lu","year":"2017","journal-title":"Lancet"},{"key":"2022100315501636800_CIT0014","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/hr.2013.57","article-title":"Prevalence, awareness, treatment and control of hypertension in elderly Chinese","volume":"36","author":"Sheng","year":"2013","journal-title":"Hypertens Res"},{"key":"2022100315501636800_CIT0015","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/HCO.0b013e3283021c70","article-title":"Hypertension and socioeconomic status","volume":"23","author":"Grotto","year":"2008","journal-title":"Curr Opin Cardiol"},{"key":"2022100315501636800_CIT0016","doi-asserted-by":"crossref","first-page":"e0124484","DOI":"10.1371\/journal.pone.0124484","article-title":"Use of medications and lifestyles of hypertensive patients with high risk of cardiovascular disease in rural China","volume":"10","author":"Zou","year":"2015","journal-title":"PLoS One"},{"key":"2022100315501636800_CIT0017","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.117.032380","article-title":"Status of hypertension in China: results from the China hypertension survey, 2012\u20132015","volume":"137","author":"Wang","year":"2018","journal-title":"Circulation"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpaa094\/33450293\/hpaa094.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/33\/9\/846\/46333079\/ajh_33_9_846.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/33\/9\/846\/46333079\/ajh_33_9_846.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T15:55:13Z","timestamp":1664812513000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/33\/9\/846\/5855769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":17,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,6,10]]},"published-print":{"date-parts":[[2020,9,10]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpaa094","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9,1]]},"published":{"date-parts":[[2020,6,10]]}}}